Standard Biotools | FLDM - Assets


Standard Biotools reported $639.11M in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Agilent USD 13.07B 252M Mar/2026
Becton, Dickinson and Co. USD 50.83B 4.01B Mar/2026
Bio-Rad Laboratories USD 9.79B 786.5M Mar/2026
Bruker USD 6.13B 110.7M Mar/2026
Danaher USD 83.54B 80M Mar/2026
Illumina USD 6.56B 85M Mar/2026
Myriad Genetics USD 673.7M 32.9M Mar/2026
Nikon Corporation JPY 1.08T 24.82B Mar/2026
Pacific Biosciences Of California USD 782.36M 1.72M Mar/2026
Revvity USD 12B 171.82M Mar/2026
Roche Holding CHF 100.7B 5.94B Dec/2025
Sony JPY 15.68T 201.48B Mar/2026
Standard Biotools USD 639.11M 71.36M Mar/2026
Thermo Fisher Scientific USD 113.28B 2.94B Mar/2026
Waters USD 24.53B 19.45B Mar/2026